Equities

ARYA Sciences Acquisition IV Corp

ARYD:NAQ

ARYA Sciences Acquisition IV Corp

Actions
  • Price (USD)10.19
  • Today's Change-0.013 / -0.13%
  • Shares traded2.26k
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of Jul 27 2021 18:49 BST.
More ▼
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Profile data is unavailable for this security.

About the company

ARYA Sciences Acquisition Corp IV is a blank check company. The Company is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities. The Company is focused on healthcare or healthcare related industries. The Company has no operations and has not generated revenues.

  • Revenue in USD (TTM)--
  • Net income in USD--
  • Incorporated2020
  • Employees--
  • Location
    ARYA Sciences Acquisition IV Corp51 Astor Place, 10Th Floor, 10th FloorNEW YORK 10003United StatesUSA
  • Phone+1 (212) 284-2300
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Altimar Acquisition Corp III-100.00bn-100.00bn189.21m----1.32----------7.36----------------------------0.00--------------
Bcls Acquisition Corp-100.00bn-100.00bn189.36m----1.35----------7.57----------------------------0.0004--------------
Bny Mellon Municipal Income Inc11.55m19.24m190.08m2.60k9.880.9889--16.450.9270.9270.556710.720.039--2.64--6.542.666.572.6680.1478.88167.8760.11----0.00130.70-6.60-2.58-87.60-25.86---7.79
Western Asset Mortgage Capital Corp234.20m61.37m190.95m1.001.930.7356--0.81541.621.623.894.270.073--1.85--1.92-0.85251.93-0.87832.20-4.7726.24-31.93----0.9179---162.20---566.49-----30.61
Morgan Stanley Emerging Mkt Debt FundInc-100.00bn-100.00bn191.02m--------------------------------------------------------------
Aberdeen Income Credit Strategies Fund-100.00bn-100.00bn193.64m--------------------------------------------------------------
Living 3D Holdings Inc36.76k-360.01k194.42m12.00------5,288.82-0.0051-0.00510.0005-0.01240.363--5.13---355.53121.08-----70.59-79.51-979.351,619.00---------50.06-7.64-25.33------
Nuveen Intermediate Duration Qlty Mun FD8.23m8.78m195.67m--22.301.01--23.780.67010.67010.628414.750.0332--1.43--3.553.193.563.2472.2871.37106.6490.99----0.224877.610.1564-3.60-57.050.7452---8.73
ARYA Sciences Acquisition IV Corp-100.00bn-100.00bn195.70m----1.34----------7.59----------------------------0.00--------------
Tuscan Holdings Corp II0.00-629.36k195.86m2.00--0.3206-----0.0287-0.02870.0031.350.00----0.00-0.3593---0.3598-------------1.210.00-------1,562.26------
Ecofin Sustainable and Soci Imp Term Fnd11.76m6.86m196.43m--28.650.9187--16.710.50820.50820.871315.850.0454--7.33--2.65--2.66--67.78--58.33----15.980.1270--50.10--131.00------
Research Alliance II Corp-100.00bn-100.00bn197.72m----1.36----------7.60----------------------------0.00--------------
Ellsworth Growth and Income Fund Ltd3.77m74.55m198.31m--2.621.03--52.645.605.600.282216.450.0194--0.8894--39.1711.6539.7411.7459.0669.012,020.43472.36----0.0043.95-4.254.57200.83----17.41
Shelter Acquisition Corporation I-100.00bn-100.00bn199.80m--------------------------------------------------------------
Kemiao Garment Holding Group0.00-59.76k200.31m-----------0.2471-0.24710.00-0.0011-------------------------------------100.45------
Clough Global Equity Fund-100.00bn-100.00bn202.03m--------------------------------------------------------------
Data as of Jul 27 2021. Currency figures normalised to ARYA Sciences Acquisition IV Corp's reporting currency: US Dollar USD

Institutional shareholders

52.10%Per cent of shares held by top holders
HolderShares% Held
HealthCor Management LPas of 31 Mar 20211.16m7.50%
RA Capital Management LPas of 31 Mar 20211.00m6.47%
Adage Capital Management LPas of 31 Mar 20211.00m6.47%
Tybourne Capital Management (HK) Ltd.as of 30 Jun 20211.00m6.47%
Farallon Capital Management LLCas of 31 Mar 2021800.00k5.18%
Tavistock Life Sciences Co. (Investment Management)as of 31 Mar 2021750.00k4.86%
Affinity Asset Advisors LLCas of 31 Mar 2021700.00k4.53%
Alyeska Investment Group LPas of 31 Mar 2021595.30k3.85%
Pura Vida Investments LLCas of 31 Mar 2021544.16k3.52%
Avidity Partners Management LPas of 31 Mar 2021500.00k3.24%
More ▼
Data from 31 Mar 2021 - 30 Jun 2021Source: FactSet Research Systems Inc.
Refinitiv, an LSEG business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.